Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC

Cancer Cell

Volumn 21, Issue 5, 2012, Pages 601-613

  Swartling, Fredrik J ^a,b   Savov, Vasil ^b   Persson, Anders I ^a   Chen, Justin ^a   Hackett, Christopher S ^a   Northcott, Paul A ^c   Grimmer, Matthew R ^a   Lau, Jasmine ^a   Chesler, Louis ^d   Perry, Arie ^a   Phillips, Joanna J ^a   Taylor, Michael D ^c   Weiss, William A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR SOX9;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN STEM; BRAIN TUMOR; CARCINOGENESIS; CEREBELLUM; FOREBRAIN; GENE EXPRESSION; GLIOMA; MOUSE; NEURAL STEM CELL; NEUROECTODERM TUMOR; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL;

ERINACEIDAE; MURINAE;

EID: 84861399134     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.04.012     Document Type: Article

References (58)

1. Ahn S., Joyner A.L. In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog. Nature 2005, 437:894-897.
2. Akazawa C., Ishibashi M., Shimizu C., Nakanishi S., Kageyama R. A mammalian helix-loop-helix factor structurally related to the product of Drosophila proneural gene atonal is a positive transcriptional regulator expressed in the developing nervous system. J. Biol. Chem. 1995, 270:8730-8738.
3. Alcock J., Sottile V. Dynamic distribution and stem cell characteristics of Sox1-expressing cells in the cerebellar cortex. Cell Res. 2009, 19:1324-1333.
4. Bagheri-Fam S., Barrionuevo F., Dohrmann U., Günther T., Schüle R., Kemler R., Mallo M., Kanzler B., Scherer G. Long-range upstream and downstream enhancers control distinct subsets of the complex spatiotemporal Sox9 expression pattern. Dev. Biol. 2006, 291:382-397.
5. Brennan C., Momota H., Hambardzumyan D., Ozawa T., Tandon A., Pedraza A., Holland E. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS ONE 2009, 4:e7752.
6. Browd S.R., Kenney A.M., Gottfried O.N., Yoon J.W., Walterhouse D., Pedone C.A., Fults D.W. N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma. Cancer Res. 2006, 66:2666-2672.
7. Charron J., Malynn B.A., Fisher P., Stewart V., Jeannotte L., Goff S.P., Robertson E.J., Alt F.W. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev. 1992, 6(12A):2248-2257.
8. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068. Cancer Genome Atlas Research Network.
9. Cho Y.J., Tsherniak A., Tamayo P., Santagata S., Ligon A., Greulich H., Berhoukim R., Amani V., Goumnerova L., Eberhart C.G., et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J. Clin. Oncol. 2011, 29:1424-1430.
10. de Bont J.M., Kros J.M., Passier M.M., Reddingius R.E., Sillevis Smitt P.A., Luider T.M., den Boer M.L., Pieters R. Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro-oncol. 2008, 10:648-660.
11. Doetsch F., Caillé I., Lim D.A., García-Verdugo J.M., Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999, 97:703-716.
12. Eberhart C.G., Kratz J., Wang Y., Summers K., Stearns D., Cohen K., Dang C.V., Burger P.C. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. J. Neuropathol. Exp. Neurol. 2004, 63:441-449.
13. Ellison D.W., Dalton J., Kocak M., Nicholson S.L., Fraga C., Neale G., Kenney A.M., Brat D.J., Perry A., Yong W.H., et al. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol. 2011, 121:381-396.
14. Farah M.H., Olson J.M., Sucic H.B., Hume R.I., Tapscott S.J., Turner D.L. Generation of neurons by transient expression of neural bHLH proteins in mammalian cells. Development 2000, 127:693-702.
15. Gibson P., Tong Y., Robinson G., Thompson M.C., Currle D.S., Eden C., Kranenburg T.A., Hogg T., Poppleton H., Martin J., et al. Subtypes of medulloblastoma have distinct developmental origins. Nature 2010, 468:1095-1099.
16. Hatton B.A., Knoepfler P.S., Kenney A.M., Rowitch D.H., de Alborán I.M., Olson J.M., Eisenman R.N. N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth. Cancer Res. 2006, 66:8655-8661.
17. Holland E.C., Varmus H.E. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc. Natl. Acad. Sci. USA 1998, 95:1218-1223.
18. Holland E.C., Celestino J., Dai C., Schaefer L., Sawaya R.E., Fuller G.N. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 2000, 25:55-57.
19. Huang X., Liu J., Ketova T., Fleming J.T., Grover V.K., Cooper M.K., Litingtung Y., Chiang C. Transventricular delivery of Sonic hedgehog is essential to cerebellar ventricular zone development. Proc. Natl. Acad. Sci. USA 2010, 107:8422-8427.
20. Hui A.B., Lo K.W., Yin X.L., Poon W.S., Ng H.K. Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab. Invest. 2001, 81:717-723.
21. Johnson R.A., Wright K.D., Poppleton H., Mohankumar K.M., Finkelstein D., Pounds S.B., Rand V., Leary S.E., White E., Eden C., et al. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 2010, 466:632-636.
22. Kawauchi D., Robinson G., Uziel T., Gibson P., Rehg J., Gao C., Finkelstein D., Qu C., Pounds S., Ellison D.W., et al. A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell 2012, 21:168-180.
23. Kessler J.D., Hasegawa H., Brun S.N., Emmenegger B.A., Yang Z.J., Dutton J.W., Wang F., Wechsler-Reya R.J. N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma. Genes Dev. 2009, 23:157-170.
24. Klein C., Butt S.J., Machold R.P., Johnson J.E., Fishell G. Cerebellum- and forebrain-derived stem cells possess intrinsic regional character. Development 2005, 132:4497-4508.
25. Knoepfler P.S., Cheng P.F., Eisenman R.N. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 2002, 16:2699-2712.
26. Kool M., Koster J., Bunt J., Hasselt N.E., Lakeman A., van Sluis P., Troost D., Meeteren N.S., Caron H.N., Cloos J., et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS ONE 2008, 3:e3088.
27. Korshunov A., Remke M., Kool M., Hielscher T., Northcott P.A., Williamson D., Pfaff E., Witt H., Jones D.T., Ryzhova M., et al. Biological and clinical heterogeneity of MYCN-amplified medulloblastoma. Acta Neuropathol. 2011, 123:515-527.
28. Lee A., Kessler J.D., Read T.A., Kaiser C., Corbeil D., Huttner W.B., Johnson J.E., Wechsler-Reya R.J. Isolation of neural stem cells from the postnatal cerebellum. Nat. Neurosci. 2005, 8:723-729.
29. Ligon K.L., Alberta J.A., Kho A.T., Weiss J., Kwaan M.R., Nutt C.L., Louis D.N., Stiles C.D., Rowitch D.H. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J. Neuropathol. Exp. Neurol. 2004, 63:499-509.
30. Lin J.C., Cai L., Cepko C.L. The external granule layer of the developing chick cerebellum generates granule cells and cells of the isthmus and rostral hindbrain. J. Neurosci. 2001, 21:159-168.
31. Marino S., Vooijs M., van Der Gulden H., Jonkers J., Berns A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 2000, 14:994-1004.
32. Merkle F.T., Mirzadeh Z., Alvarez-Buylla A. Mosaic organization of neural stem cells in the adult brain. Science 2007, 317:381-384.
33. Northcott P.A., Fernandez-L A., Hagan J.P., Ellison D.W., Grajkowska W., Gillespie Y., Grundy R., Van Meter T., Rutka J.T., Croce C.M., et al. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res. 2009, 69:3249-3255.
34. Northcott P.A., Korshunov A., Witt H., Hielscher T., Eberhart C.G., Mack S., Bouffet E., Clifford S.C., Hawkins C.E., French P., et al. Medulloblastoma comprises four distinct molecular variants. J. Clin. Oncol. 2011, 29:1408-1414.
35. Palma V., Lim D.A., Dahmane N., Sánchez P., Brionne T.C., Herzberg C.D., Gitton Y., Carleton A., Alvarez-Buylla A., Ruiz i Altaba A. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain. Development 2005, 132:335-344.
36. Pei Y., Moore C.E., Wang J., Tewari A.K., Eroshkin A., Cho Y.J., Witt H., Korshunov A., Read T.A., Sun J.L., et al. An animal model of MYC-driven medulloblastoma. Cancer Cell 2012, 21:155-167.
37. Perry A., Miller C.R., Gujrati M., Scheithauer B.W., Zambrano S.C., Jost S.C., Raghavan R., Qian J., Cochran E.J., Huse J.T., et al. Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases. Brain Pathol. 2009, 19:81-90.
38. Pfister S., Remke M., Benner A., Mendrzyk F., Toedt G., Felsberg J., Wittmann A., Devens F., Gerber N.U., Joos S., et al. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J. Clin. Oncol. 2009, 27:1627-1636.
39. Polkinghorn W.R., Tarbell N.J. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification. Nat. Clin. Pract. Oncol. 2007, 4:295-304.
40. Pomeroy S.L., Tamayo P., Gaasenbeek M., Sturla L.M., Angelo M., McLaughlin M.E., Kim J.Y., Goumnerova L.C., Black P.M., Lau C., et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002, 415:436-442.
41. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710.
42. Salghetti S.E., Kim S.Y., Tansey W.P. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 1999, 18:717-726.
43. Salsano E., Croci L., Maderna E., Lupo L., Pollo B., Giordana M.T., Consalez G.G., Finocchiaro G. Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1. Neuro-oncol. 2007, 9:298-307.
44. Schmitt A., Asan E., Püschel B., Jöns T., Kugler P. Expression of the glutamate transporter GLT1 in neural cells of the rat central nervous system: non-radioactive in situ hybridization and comparative immunocytochemistry. Neuroscience 1996, 71:989-1004.
45. Schüller U., Heine V.M., Mao J., Kho A.T., Dillon A.K., Han Y.G., Huillard E., Sun T., Ligon A.H., Qian Y., et al. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 2008, 14:123-134.
46. Scott C.E., Wynn S.L., Sesay A., Cruz C., Cheung M., Gomez Gaviro M.V., Booth S., Gao B., Cheah K.S., Lovell-Badge R., Briscoe J. SOX9 induces and maintains neural stem cells. Nat. Neurosci. 2010, 13:1181-1189.
47. Stanton B.R., Perkins A.S., Tessarollo L., Sassoon D.A., Parada L.F. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev. 1992, 6(12A):2235-2247.
48. Stolt C.C., Lommes P., Sock E., Chaboissier M.C., Schedl A., Wegner M. The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev. 2003, 17:1677-1689.
49. Storm R., Cholewa-Waclaw J., Reuter K., Bröhl D., Sieber M., Treier M., Müller T., Birchmeier C. The bHLH transcription factor Olig3 marks the dorsal neuroepithelium of the hindbrain and is essential for the development of brainstem nuclei. Development 2009, 136:295-305.
50. Sutter R., Shakhova O., Bhagat H., Behesti H., Sutter C., Penkar S., Santuccione A., Bernays R., Heppner F.L., Schüller U., et al. Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Oncogene 2010, 29:1845-1856.
51. Swartling F.J., Ferletta M., Kastemar M., Weiss W.A., Westermark B. Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene 2009, 28:3121-3131.
52. Swartling F.J., Grimmer M.R., Hackett C.S., Northcott P.A., Fan Q.W., Goldenberg D.D., Lau J., Masic S., Nguyen K., Yakovenko S., et al. Pleiotropic role for MYCN in medulloblastoma. Genes Dev. 2010, 24:1059-1072.
53. Taipale J., Chen J.K., Cooper M.K., Wang B., Mann R.K., Milenkovic L., Scott M.P., Beachy P.A. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 2000, 406:1005-1009.
54. Taylor M.D., Northcott P.A., Korshunov A., Remke M., Cho Y.J., Clifford S.C., Eberhart C.G., Parsons D.W., Rutkowski S., Gajjar A., et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 2011, 123:465-472.
55. Thompson M.C., Fuller C., Hogg T.L., Dalton J., Finkelstein D., Lau C.C., Chintagumpala M., Adesina A., Ashley D.M., Kellie S.J., et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J. Clin. Oncol. 2006, 24:1924-1931.
56. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 2001, 98:5116-5121.
57. Vidal V.P., Chaboissier M.C., Lützkendorf S., Cotsarelis G., Mill P., Hui C.C., Ortonne N., Ortonne J.P., Schedl A. Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment. Curr. Biol. 2005, 15:1340-1351.
58. Yang Z.J., Ellis T., Markant S.L., Read T.A., Kessler J.D., Bourboulas M., Schüller U., Machold R., Fishell G., Rowitch D.H., et al. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 2008, 14:135-145.